Tjiptaningrum, Agustyas and Intanri Kurniati, Intanri Kurniati and Putu, Ristyaning Ayu Sangging and Liana, Sidharti (2021) ANALYSIS OF MEAN DIFFERENCE OF TOTAL S-RBD SARSCoV2 BETWEEN POST CORONAVAC VACCINATION AND COVID-19 SURVIVAL. In: 2nd ICAMS: International Conference on Agromedicine and Medical Sciences 2021, 25-26 Oktober 2021, Bandar Lampung.
|
Text
Abstrak ICAM 2021.pdf Download (147kB) | Preview |
Abstract
ANALYSIS OF MEAN DIFFERENCE OF TOTAL S-RBD SARSCoV2 BETWEEN POST CORONAVAC VACCINATION AND COVID-19 SURVIVAL Agustyas Tjiptaningrum1*, Intanri Kurniati2, Putu Ristyaning Ayu3, Liana Sidharti4 1Clinical Pathology Laboratory of Faculty of Medicine of University of Lampung, Bandarlampung, Indonesia, agustyas.tjiptaningrum@fk.unila.ac.id 21Clinical Pathology Laboratory of Faculty of Medicine of University of Lampung, Bandarlampung, Indonesia,intanridr@gmail.com 31Clinical Pathology Laboratory of Faculty of Medicine of University of Lampung, Bandarlampung, Indonesia, ristya.ayu@gmail.com *Corresponding author. Email:tyaskirani@gmail.com ABSTRACT Reason for writing Corona virus disease-19 (Covid-19) is a health problem at Indonesia. The cumulative cases of Covid-19 at Indonesia is 4,235,384 cases and the cumulative deaths is 142,999. The case fatality rate (CFR) is about 3.3%. Socialization of health protocols is performed to prevent of the Covid-19 spreading. The health protocols include wearing mask in public area activity, physical and social distancing and washing hands with soap or hand sanitizer regularly. The addition thing to control Covid-19 is Covid-19 vaccination. One of type vaccine is inactivated virus vaccine that use of a form of the virus that has been inactivated. CoronaVac vaccine is a inactivated vaccine that has been used at Indonesia. Both of Covid-19 survival and post CoronaVac Vaccination can produce neutralizer antibody. The aim of this study was to analyse a mean difference of total S-RBD SARSCoV-2 antibody level between post Coronavac vaccination and Covid-19 survival. Methodology This study was analytic descriptive research with cross-sectional approach. It was conducted at FK-Unila Lampung and Sariasih hospital at Banten. Population of this study was Covid-19 survival and CoronaVac vaccinated people. Subjects were taken by consecutive sampling. We measured level of total neutralizer antibody by examination of S-RBD SARSCoV-2 antibody. We used Independent-t Test to analyze of a mean difference of total antibody level between post CoronaVac vaccination and Covid-19 Survival. Result There was a significant mean difference of S-RBD SARSCoV-2 antibody level between post CoronaVac vaccination and Covid-19 survival (p=0.02). The mean of post CoronaVac Vaccination was 99.8 U/mL whereas the mean of Covid-19 survival was 232.13 U/mL. Keywords: Covid-19, CoronaVac, Survival, Vaccination
Item Type: | Conference or Workshop Item (Speech) |
---|---|
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine |
Divisions: | Fakultas Kedokteran (FK) > Prodi Pendidikan Dokter |
Depositing User: | dr, Sp.PK Agustyas Tjiptaningrum |
Date Deposited: | 11 Nov 2021 04:54 |
Last Modified: | 11 Nov 2021 04:54 |
URI: | http://repository.lppm.unila.ac.id/id/eprint/35313 |
Actions (login required)
View Item |